Notícias

Block (NYSE:XYZ) is expanding its Square partnership with Ideal Nutrition as the meal prep brand rolls out nationally across the US. Ideal Nutrition is adopting Square tools across in-store POS, online ordering, loyalty programs, and franchise management for its expansion. The rollout includes AI-driven demand forecasting and cross-platform integrations that link Ideal Nutrition’s retail, logistics, and customer data in one system. Ideal Nutrition’s Square-powered national expansion and...

Cisco Systems (NasdaqGS:CSCO) announced a collaboration with quantum technology firm Infleqtion to advance distributed quantum networking architectures. The partners plan to work on quantum memory to optical transduction and networked quantum devices for long distance connectivity. Cisco highlighted a prototype Universal Quantum Switch as part of its push to connect, operate, and scale quantum systems. The Infleqtion partnership and Universal Quantum Switch prototype only capture one part of...

Micron is enjoying a generational demand wave.

Royal Caribbean Group (NYSE:RCL) has agreed to acquire a 50% stake in Sandals and Beaches Resorts for approximately $3 billion, expanding the cruise operator’s business into the all-inclusive resort market. The companies said Wednesday that the investment will create a joint venture combining the Caribbean resort portfolio of Sandals and Beaches with Royal Caribbean’s cruise, private destination and vacation operations.

Novo Nordisk (NYSE:NVO) would be open to considering a direct listing of its shares on the New York Stock Exchange, Chief Executive Mike Doustdar told the Financial Times in an interview published Wednesday. Doustdar said he could see advantages to such a move when asked about the possibility, although he clarified that the Danish pharmaceutical company is not currently exploring a change to its U.

The Hashgraph Group (THG) has listed its IDTrust identity software on IBM’s (NYSE:IBM) Cloud Catalog and entered into a global partnership with the U. S.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

D-Wave still trades at a lofty valuation despite its stock slump.

Backed by a former J&J CEO, the startup plans to advance its drug candidates into late-stage trials.

The AI boom relies on this key metric.

Zest Protocol's capped mainnet demo lets users borrow USDC against BTC held in a vault on Bitcoin, without wrapping or bridging the coins.

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.

CEO BRIEF NEWSLETTER When you’re talking with Chevron’s CFO, you first ask the question so many business leaders are grappling with. “We’ve got crude oil prices up, what, 50% since the start of the [Iran] war.

The company's augmented reality glasses, called Specs, retail for more than $2,000.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Warner Bros. (WBD) unit CNN, Versant Media (VSNT) unit MS Now, and Politico's ban from the White Hou

Under the arrangement, Gopuff will become part of the Instacart Marketplace and will use Carrot Ads to run advertising on its own online storefront.

The Commerce Department secretary and the firm he used to run, Cantor Fitzgerald, placed big bets on USA Rare Earth’s unproven assets.

Apple’s iPhones, for example, are projected by Wall Street analysts to generate 17% more revenue this calendar year, according to FactSet. The main reason for the disconnect between sales and revenue are memory chip prices, which are being driven higher by the AI race.

U. S. stock futures moved slightly higher on Wednesday as investors monitored developments around Meta Platforms’ (NASDAQ:META) Muse AI agent, Middle East diplomacy and upcoming U.

Sandisk led the S&P 500 higher last year, and it's once again the best-performing stock in the index this year.

The partnership will enable agentic checkout via Shop Pay across the platform's full roster of stores.

The Oracle of Omaha’s protégé is finding deals aplenty in one overseas market.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Palantir is up nearly 2,700% from its low and has emerged as a leading SaaS stock.

These are among the highest-yielding stocks on the S&P 500.

Energy markets are on edge as the Iran conflict disrupts oil supply, and the Federal Reserve keeps lifting interest rates to fight stubborn inflation. Power that is not tied to fossil fuels suddenly matters more to Canadian investors. Nuclear-focused companies sit squarely in that conversation. This article walks through three nuclear energy stocks from the Canadian market that can help you study this theme in a focused and time efficient way. The three nuclear energy stocks covered below are...

D-Wave Quantum (QBTS) has just added veteran financial technology executive Bernard Gavgani to its Board of Directors and Cybersecurity Committee, giving investors a fresh governance angle to assess alongside recent insider selling trends. Recent trading tells a mixed story for D-Wave Quantum. The share price is down 37.58% year to date and 23.59% over 90 days. However, the 7 day share price return of 7.01% hints at short term momentum within a much weaker long term trend, even after a very...

Biogen (BIIB) is back in focus after publishing adolescent subgroup data from its Phase 3 VALIANT trial of EMPAVELI in rare kidney diseases, a catalyst that gives investors fresh clinical context around the stock. For context, Biogen’s recent clinical and product news has landed against a backdrop of stronger trading action, with a 1-day share price return of 2.87% on the latest close at US$225.36 and a 90-day share price return of 12.91%. Investors are weighing kidney and Alzheimer’s updates...